Profile data is unavailable for this security.
About the company
GVS SpA is an Italy-based manufacturer of filters and components for applications in the healthcare, life sciences, automotive, appliance, safety, commercial and industrial filtration. Its offering includes seven product lines: Healthcare, Laboratory, Mobility, Air Safety, Appliance, Personal Safety and Membranes. Each product line provides a suite of customizable solutions specifically related to each market. Additionally, the Company offers tailormade product and process development services, which cover all the project stages, including product and process design, validation, up to the mass production for large quantities. It is active globally.
- Revenue in EUR (TTM)424.67m
- Net income in EUR20.54m
- Incorporated1992
- Employees4.39k
- LocationGVS SpAVia Roma, 50ZOLA PREDOSA 40069ItalyITA
- Websitehttps://www.gvs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| medmix AG | 502.45m | 309.77k | 716.64m | 2.66k | 1,678.64 | 1.47 | 12.39 | 1.43 | 0.01 | 0.01 | 11.91 | 11.41 | 0.4606 | 3.65 | 6.05 | 183,070.00 | 0.0663 | 2.06 | 0.0846 | 2.49 | 32.41 | 36.38 | 0.1439 | 4.16 | 1.23 | 2.92 | 0.4244 | 67.70 | 1.99 | 1.40 | -97.41 | -64.36 | 12.01 | -- |
| Paul Hartmann AG | 2.35bn | 28.42m | 717.46m | 10.17k | 25.12 | 0.6713 | 5.28 | 0.3049 | 8.00 | 8.00 | 662.57 | 299.40 | 1.18 | 2.02 | 5.72 | 231,438.00 | 1.64 | 3.87 | 2.26 | 5.34 | 56.01 | 56.71 | 1.39 | 2.98 | 1.16 | 4.87 | 0.1865 | 42.75 | 1.80 | 2.12 | -21.37 | -18.49 | 5.95 | 2.71 |
| Revenio Group Oyj | 96.68m | 19.01m | 750.27m | 216.00 | 39.03 | 7.49 | 32.69 | 7.76 | 0.7205 | 0.7205 | 3.66 | 3.76 | 0.7069 | 5.50 | 7.60 | 447,574.10 | 13.90 | 14.33 | 16.77 | 17.90 | 51.01 | 50.73 | 19.66 | 21.13 | 1.79 | 28.49 | 0.1521 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
| Synsam AB (publ) | 531.47m | 30.75m | 779.32m | 3.52k | 25.15 | 3.37 | 8.06 | 1.47 | 2.34 | 2.34 | 40.45 | 17.46 | 0.7272 | 2.05 | 10.94 | 1,762,379.00 | 4.18 | -- | 5.85 | -- | 75.31 | -- | 5.75 | -- | 0.50 | -- | 0.5659 | -- | 11.90 | -- | -5.18 | -- | -- | -- |
| El En SpA | 692.29m | 48.24m | 805.49m | 2.11k | 16.66 | 2.32 | 13.01 | 1.16 | 0.6038 | 0.6038 | 8.67 | 4.33 | 0.9515 | 2.04 | 4.05 | 332,511.90 | 6.88 | 7.43 | 12.83 | 13.52 | 39.14 | 38.83 | 7.23 | 7.63 | 1.20 | 232.14 | 0.164 | -- | 2.78 | 14.88 | -12.47 | 23.49 | -13.40 | -- |
| Draegerwerk AG & Co KGaA | 3.35bn | 100.48m | 907.05m | 16.48k | 8.72 | 0.6117 | 3.61 | 0.2709 | 5.36 | 5.36 | 178.48 | 76.35 | 1.11 | 2.61 | 4.94 | 205,046.00 | 3.39 | 3.26 | 5.03 | 4.87 | 43.32 | 44.16 | 3.06 | 3.05 | 1.17 | 5.79 | 0.1662 | 11.38 | 10.78 | 5.39 | 271.05 | 33.87 | 2.64 | 55.73 |
| Arjo AB (publ) | 980.86m | 45.77m | 1.04bn | 6.71k | 24.36 | 1.56 | 7.60 | 1.06 | 1.90 | 1.90 | 40.76 | 29.72 | 0.6911 | 4.15 | 6.31 | 1,632,980.00 | 3.21 | 3.55 | 4.44 | 5.55 | 43.43 | 44.01 | 4.64 | 5.41 | 0.6913 | 4.14 | 0.4024 | 43.01 | 10.03 | 5.97 | 6.90 | 10.15 | -8.89 | 10.35 |
| Medartis Holding AG | 218.91m | 639.17k | 1.07bn | 829.00 | 1,567.62 | 3.71 | 48.05 | 4.90 | 0.0488 | 0.0488 | 17.33 | 20.63 | 0.6259 | 0.643 | 5.27 | 255,737.00 | 0.183 | 0.1919 | 0.2095 | 0.2153 | 79.04 | 82.33 | 0.2924 | 0.3542 | 1.59 | 1.46 | 0.1655 | 0.00 | 15.96 | 11.81 | 110.70 | -31.82 | 5.37 | -- |
| Oxford Nanopore Technologies PLC | 199.27m | -181.46m | 1.09bn | 1.24k | -- | 1.43 | -- | 5.46 | -0.1851 | -0.1851 | 0.2035 | 0.7493 | 0.212 | 0.8369 | 2.73 | 137,050.10 | -19.30 | -21.12 | -21.93 | -24.67 | 53.33 | 53.90 | -91.06 | -81.85 | 3.87 | -- | 0.0608 | -- | -14.57 | 39.15 | -69.74 | -- | 8.92 | -- |
| GVS SpA | 424.67m | 20.54m | 1.16bn | 4.39k | 58.40 | 3.34 | 17.74 | 2.73 | 0.1135 | 0.1135 | 2.38 | 1.99 | 0.4201 | 1.95 | 6.20 | 96,823.30 | 2.03 | 7.35 | 2.50 | 10.82 | 53.92 | 58.74 | 4.84 | 12.44 | 1.19 | 3.87 | 0.5709 | -- | 9.58 | 15.25 | -43.37 | -9.97 | 16.08 | -- |
| Xvivo Perfusion AB | 56.81m | 8.87m | 1.22bn | 148.00 | 132.65 | 6.92 | 84.07 | 21.56 | 3.32 | 3.32 | 21.18 | 63.59 | 0.322 | 1.28 | 4.27 | 4,018,431.00 | 5.03 | 1.24 | 5.49 | 1.33 | 73.94 | 73.14 | 15.62 | 4.76 | 3.40 | -- | 0.0152 | 0.00 | 43.88 | 26.04 | 398.29 | 48.57 | 21.35 | -- |
| Biotage AB | 175.04m | 20.85m | 1.31bn | 669.00 | 61.58 | 3.81 | 36.81 | 7.49 | 3.01 | 3.01 | 25.57 | 48.61 | 0.5276 | 2.01 | 7.78 | 2,939,169.00 | 6.29 | 10.74 | 7.33 | 12.77 | 62.19 | 61.34 | 11.91 | 15.77 | 1.52 | 8.95 | 0.062 | 40.11 | 18.90 | 15.37 | -8.21 | 7.97 | 14.05 | 1.30 |
| Embla Medical hf | 741.19m | 52.46m | 1.62bn | 4.00k | 30.80 | 2.40 | 16.26 | 2.19 | 0.9174 | 0.9174 | 12.95 | 11.77 | 0.5582 | 2.20 | 6.60 | 1,382,694.00 | 3.96 | 4.06 | 4.68 | 4.76 | 61.41 | 62.47 | 7.09 | 6.91 | 1.07 | 5.81 | 0.4325 | 3.99 | 9.33 | 5.09 | 37.34 | -6.05 | 6.50 | -- |
Data as of Jun 07 2024. Currency figures normalised to GVS SpA's reporting currency: Euro EUR
16.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 8.72m | 4.98% |
| Mediolanum Gestione Fondi SGRpAas of 29 Dec 2023 | 4.19m | 2.40% |
| Invesco Asset Management Ltd.as of 29 Feb 2024 | 3.00m | 1.71% |
| T. Rowe Price International Ltd.as of 31 Mar 2024 | 2.76m | 1.58% |
| The Vanguard Group, Inc.as of 09 May 2024 | 2.49m | 1.42% |
| Fideuram Asset Management SGR SpAas of 29 Apr 2024 | 1.76m | 1.00% |
| Amundi Asset Management SA (Investment Management)as of 08 May 2024 | 1.75m | 1.00% |
| Fidelity Management & Research Co. LLCas of 30 Apr 2024 | 1.55m | 0.89% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 1.19m | 0.68% |
| Oddo BHF Asset Management SASas of 30 Apr 2024 | 947.46k | 0.54% |
More ▼
Data from 29 Dec 2023 - 29 May 2024Source: FactSet Research Systems Inc.
